Search - tctmd.com

Displaying 621 - 640 of 1065

Sort: Relevancy | Date

Edoxaban Looks Good for Asians With A-fib in Real-world Analysis

News Daily News

Edoxaban Looks Good for Asians With A-fib in Real-world Analysis

August 14, 2018

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

August 09, 2018

Ischemic Stroke Risk Scoring May Not Be Accurate for Patients With Atrial Flutter

News Daily News

Ischemic Stroke Risk Scoring May Not Be Accurate for Patients With Atrial Flutter

August 03, 2018

Acute MI Rates on the Rise Among Pregnant Women in the US

News Daily News

Acute MI Rates on the Rise Among Pregnant Women in the US

July 24, 2018

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

July 16, 2018

Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis

News Daily News

Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis

July 10, 2018

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

July 02, 2018

Once Again, ISCHEMIA Trial Feels the Squeeze

News Daily News

Once Again, ISCHEMIA Trial Feels the Squeeze

Michael O'Riordan

June 29, 2018

New Estimates of Bleeding Risks May Help CVD Prevention

News Daily News

New Estimates of Bleeding Risks May Help CVD Prevention

June 27, 2018

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

News Daily News

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

June 22, 2018

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

News Daily News

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

June 19, 2018

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

News Daily News

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

June 18, 2018

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

News Daily News

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

Yael L. Maxwell

June 14, 2018

Silent A-fib That Progresses Signals a Higher Heart Failure Risk

News Daily News

Silent A-fib That Progresses Signals a Higher Heart Failure Risk

June 06, 2018

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

News Daily News

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

June 04, 2018

Financial Burden of Hypertension Weighs Heavily on US Population

News Daily News

Financial Burden of Hypertension Weighs Heavily on US Population

May 30, 2018

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

News Daily News

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

May 11, 2018

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

News Daily News

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Michael O'Riordan

May 10, 2018

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.